199 related articles for article (PubMed ID: 14551521)
1. Acetylcysteine for the prevention of radiocontrast -induced nephropathy.
Tepel M
Minerva Cardioangiol; 2003 Oct; 51(5):525-30. PubMed ID: 14551521
[TBL] [Abstract][Full Text] [Related]
2. Acetylcysteine and contrast media nephropathy.
Tepel M; Zidek W
Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):503-6. PubMed ID: 12187314
[TBL] [Abstract][Full Text] [Related]
3. Acetylcysteine for radiocontrast nephropathy.
Tepel M; Zidek W
Curr Opin Crit Care; 2001 Dec; 7(6):390-2. PubMed ID: 11805540
[TBL] [Abstract][Full Text] [Related]
4. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Boccalandro F; Amhad M; Smalling RW; Sdringola S
Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
[TBL] [Abstract][Full Text] [Related]
5. Acetylcysteine for prevention of contrast nephropathy: meta-analysis.
Birck R; Krzossok S; Markowetz F; Schnülle P; van der Woude FJ; Braun C
Lancet; 2003 Aug; 362(9384):598-603. PubMed ID: 12944058
[TBL] [Abstract][Full Text] [Related]
6. [Pathophysiology and prevention of contrast-induced acute renal failure].
Graziani G; Degnoni V; Oldani S; Buskermolen M; Brambilla G
G Ital Nefrol; 2007; 24 Suppl 38():20-4. PubMed ID: 17922443
[TBL] [Abstract][Full Text] [Related]
7. A review of contemporary prevention strategies for radiocontrast nephropathy: a focus on fenoldopam and N-acetylcysteine.
Lepor NE
Rev Cardiovasc Med; 2003; 4 Suppl 1():S15-20. PubMed ID: 12556733
[TBL] [Abstract][Full Text] [Related]
8. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
[TBL] [Abstract][Full Text] [Related]
9. [New usage for an old drug: acetylcysteine for contrast-induced nephropathy].
Asher I; Hammerman A; Sthoeger Z
Harefuah; 2005 Sep; 144(9):642-6; 675. PubMed ID: 16218537
[TBL] [Abstract][Full Text] [Related]
10. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury.
Drager LF; Andrade L; Barros de Toledo JF; Laurindo FR; Machado César LA; Seguro AC
Nephrol Dial Transplant; 2004 Jul; 19(7):1803-7. PubMed ID: 15128882
[TBL] [Abstract][Full Text] [Related]
11. Prevention of contrast-induced nephropathy in vascular surgery patients.
Lawlor DK; Moist L; DeRose G; Harris KA; Lovell MB; Kribs SW; Elliot J; Forbes TL
Ann Vasc Surg; 2007 Sep; 21(5):593-7. PubMed ID: 17823041
[TBL] [Abstract][Full Text] [Related]
12. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.
Tepel M; van der Giet M; Schwarzfeld C; Laufer U; Liermann D; Zidek W
N Engl J Med; 2000 Jul; 343(3):180-4. PubMed ID: 10900277
[TBL] [Abstract][Full Text] [Related]
13. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D
Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691
[TBL] [Abstract][Full Text] [Related]
14. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the prevention of radiocontrast-induced nephropathy.
Marenzi G; Bartorelli AL
Curr Opin Crit Care; 2004 Dec; 10(6):505-9. PubMed ID: 15616393
[TBL] [Abstract][Full Text] [Related]
16. Preventing contrast nephropathy: what is the best strategy? A review of the literature.
Cox CD; Tsikouris JP
J Clin Pharmacol; 2004 Apr; 44(4):327-37. PubMed ID: 15051739
[TBL] [Abstract][Full Text] [Related]
17. N-Acetylcysteine in nephrology; contrast nephropathy and beyond.
Tepel M; Zidek W
Curr Opin Nephrol Hypertens; 2004 Nov; 13(6):649-54. PubMed ID: 15483456
[TBL] [Abstract][Full Text] [Related]
18. Prevention of radiocontrast-induced nephropathy.
Asif A; Epstein M
Am J Kidney Dis; 2004 Jul; 44(1):12-24. PubMed ID: 15211433
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography.
MacNeill BD; Harding SA; Bazari H; Patton KK; Colon-Hernadez P; DeJoseph D; Jang IK
Catheter Cardiovasc Interv; 2003 Dec; 60(4):458-61. PubMed ID: 14624421
[TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
